PIK-inhibitors
97%
- Product Code: 102035
CAS:
371934-59-7
Molecular Weight: | 347.378 g./mol | Molecular Formula: | C₁₉H₁₇N₅O₂ |
---|---|---|---|
EC Number: | MDL Number: | MFCD30475673 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | -20℃ |
Product Description:
PIK-inhibitors are primarily used in the field of cancer therapy. They target specific enzymes involved in the PI3K/AKT/mTOR pathway, which is crucial for cell growth, survival, and metabolism. By inhibiting these enzymes, PIK-inhibitors can effectively slow down or stop the proliferation of cancer cells. They are particularly useful in treating cancers where this pathway is overactive, such as breast, ovarian, and blood cancers. Additionally, PIK-inhibitors are being researched for their potential in treating inflammatory diseases and autoimmune disorders, where abnormal cell signaling contributes to disease progression. Their ability to modulate immune responses makes them a promising option for developing new therapeutic strategies.
Product Specification:
Test | Specification |
---|---|
Appearance | Solid |
Purity (%) | 96.5-100 |
Infrared Spectrum | Conforms To Structure |
NMR | Conforms To Structure |
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.001 | 10-20 days | $219.44 |
+
-
|
PIK-inhibitors
PIK-inhibitors are primarily used in the field of cancer therapy. They target specific enzymes involved in the PI3K/AKT/mTOR pathway, which is crucial for cell growth, survival, and metabolism. By inhibiting these enzymes, PIK-inhibitors can effectively slow down or stop the proliferation of cancer cells. They are particularly useful in treating cancers where this pathway is overactive, such as breast, ovarian, and blood cancers. Additionally, PIK-inhibitors are being researched for their potential in treating inflammatory diseases and autoimmune disorders, where abnormal cell signaling contributes to disease progression. Their ability to modulate immune responses makes them a promising option for developing new therapeutic strategies.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :